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Abstract: A series of enzymatic transformations, which generate visibly emissive isofunctional cofactors based on an isothiazolo[4,3-
d]pyrimidine analogue of adenosine (tzA), is described. Nicotinamide adenylyl transferase condenses nicotinamide mononucleotide 
and tzATP to yield NtzAD+, which can be enzymatically phosphorylated by NAD kinase and ATP or tzATP to the corresponding NtzADP+. 
The latter can be engaged in NADP-specific coupled enzymatic transformations involving conversion to NtzADPH by glucose-6-
phosphate dehydrogenase and reoxidation to NtzADP+ by glutathione reductase. The NtzADP+/NtzADPH cycle can be monitored in 
real time by emission spectroscopy. 
 
Nucleic acids and their building blocks play central roles in all cellular events, including storage, retrieval, regulation and 
expression of genetic information, as well as signalling and metabolic pathways. This extensive biology necessitates the 
development of new tools for studying their recognition properties as well as alteration by endogenous and exogenous 
agents.[1] Emissive nucleoside analogues, when judiciously fabricated and incorporated, could serve as effective photophysical 
and mechanistic probes.[2] Indeed, extensive efforts have been dedicated to the development and refinement of such tools in 
recent years.[3–5] 
Our focus over the past decade has been to design, synthesize, and implement new emissive nucleoside analogues that 
can faithfully replace their natural counterparts.[3,6] A guiding principle for the successful advancement of such probes is to 
curtail structural and functional perturbations (features defined as isomorphicity and isofunctionality, respectively), while 
endowing them with useful photophysical attributes. Several families of emissive analogs have been made and employed,[6] 
with the two emissive RNA alphabets based on the thiopheno[3,4-d]pyrimidine (thN)[7] and the isothiazolo[4,3-d]pyrimidine-
cores (tzN)[8] being most notable.[9–11] 
While the incorporation of a single modified nucleoside into an oligonucleotide could be structurally and functionally benign, as 
detrimental effects might be masked, the adequate performance of nucleosides and nucleotides as cofactors and secondary 
messengers represents a much more demanding test for their isomorphism and isofunctionality. Along these lines we have initiated 
the exploration of synthetic emissive cofactors and their metabolic interconversions by transferases, kinases and hydrolases, with the 
goal of defining their biological recognition space and potential utility for investigating signalling and metabolic pathways.[12,13] In this 
contribution, we illustrate the enzymatic synthesis of the emissive and isofunctional NtzAD+ from nicotinamide mononucleotide and 
tzATP. We then show that NtzAD+ can be enzymatically phosphorylated by NAD kinase to the corresponding NtzADP+, which in turn 
can be engaged in NADP-specific coupled enzymatic transformations involving conversion to NtzADPH by glucose-6-phosphate 
dehydrogenase and oxidation back to NtzADP+ by glutathione reductase. Rewardingly, the NtzADP+/NtzADPH cycle can be monitored 
in real time by emission spectroscopy. 
Scheme 1: Chemical synthesis of tzATP. i) POCl3, TMPP, 0°C to rt, 2 h; ii) tributylammonium pyrophosphate, TBA, 0°C to rt, 2 h, 17%. 
 
A key precursor for the enzymatic fabrication of emissive adenosine-containing cofactors is isothiazolo-adenosine 
triphosphate (tzATP), which was synthesized from the corresponding nucleoside according to common protocols (Scheme 
1).[14] To evaluate the biocompatibility of tzA-based secondary messengers/cofactors, a multienzymatic assay was used in 
which a mixture of nicotinamide mononucleotide and tzATP is treated with nicotinamide adenylyl transferase 1 (NMNAT-1) 
and subsequently with S. cerevisiae alcohol dehydrogenase (ADH). The former enzyme catalyses the transfer of nicotinamide 
mononucleotide to ATP,[15] releasing inorganic pyrophosphate, while the latter oxidizes ethanol to acetaldehyde in presence 
of NAD+ as a cofactor. Thus, to enzymatically access NtzAD+, a solution of tzATP and nicotinamide mononucleotide (NMN) in 
Tris buffer (pH 7.8) was treated with a recombinant human NMNAT-1 at 37°C. The use of an inorganic pyrophosphatase was 
found to be essential to avoid product inhibition of the transferase[16] and facilitate a quantitative reaction (conversion > 95%). 
This enzymatic transformation was followed in real time by monitoring the emission intensity at 410 nm (λex: 330 nm) (Figure 
1b). The conversion of tzATP into NtzAD+ was depicted by a significant decrease in emission intensity over a 30 minutes 
window. The in situ formed NtzAD+ was then converted to the corresponding NtzADH over 10 minutes by the addition of ADH 
and ethanol to the NMNAT-1-mediated reaction mixture. In a similar fashion to the previous enzymatic reaction, the reduction 
of NtzAD+ by ADH was characterized by a further decrease in emission intensity comparable to the one observed for the 
enzymatic conversion of tzATP into NtzAD+ (Figure 1b). Final addition of excess acetaldehyde triggered a nearly instantaneous 
enzymatic oxidation of NtzADH, recovering 80% of the original emission signal of NtzAD+.  
Steady state absorption and emission spectra recorded at the end (plateau) of each enzymatic transformation show that 
the conversion of tzATP to NtzAD+ has no or little effect on the absorption spectra of the tzA chromophore but does lead to 
diminished fluorescence (Figure 1c). Further emission quenching is seen upon reduction of NtzAD+ to NtzADH, along with an 
increase in the optical density at 333 nm, consistent with a reduced nicotinamide moiety.[17] These observations reveal the 
high photophysical responsiveness of the emissive tzA based cofactors. As a control, the same enzymatic cycle was performed 
with tzATP as the substrate, but without NMNAT-1. This reaction was monitored in real-time by ground state absorption and 
steady state fluorescence spectroscopies, showing little to no change in each corresponding spectra, thus indicating no 
conversion of tzATP over time (Figure S1).[14] 
Figure 1: a) Enzymatic cycle for NtzAD+ generation, consumption and regeneration with NMNAT-1 and ADH. b) Enzymatic transfer of NMN to tzATP 
(red) or ATP (black) by NMNAT-1 to form NtzAD+ or NAD+, followed by oxidation of ethanol to acetaldehyde with ADH, generating NtzADH (orange) and 
NADH (cyan), succeeded by a reverse enzymatic reaction with an excess of acetaldehyde to regenerate NtzAD+ (pink) and NAD+ (blue), monitored by 
real-time emission at 410 nm (λex: 330 nm) and 465 nm (λex: 335 nm) for the tzA-based and native derivatives, respectively. c) Steady state absorption 
(dashed line) and emission (solid line) spectra of tzATP (purple), in situ generated NtzAD+ (red), NtzADH (orange), and regenerated NtzAD+ (pink), taken 
at the end of each time-based enzymatic reaction.  
 
While numerous cellular processes utilize the NAD+/NADH couple, several metabolic reactions exclusively use the 
NADP+/NADPH pair, the corresponding monophosphorylated variant.[18] Natively, NAD kinase catalyses the transfer of a 
phosphate group from ATP to the 2’ hydroxyl group on the adenosine’s D-ribose moiety of NAD+, while certain bacterial NAD 
kinases can also use polyphosphate minerals as a phosphate source.[19] To assess the enzymatic syntheses of NtzADP+ and 
NtzADPH, NtzAD+ (chemically synthesized as recently described)[12b] was treated with B. subtilis NAD kinase (NADK) and 
ATP.[20] While the phosphorylation reaction was observed (Figure 2), buildup of the newly synthesized NtzADP+ resulted in 
product inhibition, as expected based on previous reports.[19b] To circumvent this issue, the kinase-mediated reaction was 
coupled to a second enzymatic system, utilizing the in situ-generated phosphorylated cofactor. Thus excess S. cerevisiae 
glucose-6-phosphate dehydrogenase (G6PDH), an enzyme responsible for the oxidation of glucose-6-phosphate (G6P),[21] 
was added to the reaction mixture. Upon coupling this enzyme to our process, the newly-formed NtzADP+ was indeed actively 
converted to NtzADPH via G6PDH, as illustrated by HPLC and HR-MS (See Figures 2d, S5 and S6). Importantly, NAD+ kinase 
can also utilize tzATP as the phosphate donor, thus illustrating a native enzyme-mediated reaction, which utilizes two distinct 
synthetic cofactors (Figure S4).[14] 
The NADK-mediated phosphorylation of NtzAD+ to NtzADP+ is, as predictable, photophysically “silent”, while the following 
reduction of the in situ formed NtzADP+ to NtzADPH via G6PDH shows significant photophysical changes, comparable to those 
seen for NtzAD+/NtzADH (Figure 2a). Thus, over 3 hours, an increase in absorbance at 333 nm and a concomitant decrease 
of the emission intensity at 410 nm (λex: 330 nm) are observed (Figure 2b). The overall reaction half-time, derived from the 
emission spectra variation over time (Figure 2c), are 3.3 and 3.6 × 102 s for the native and the tzA-based analogue nucleosides, 
respectively, assuming pseudo first-order kinetics.[14] This process was also monitored in parallel by HPLC, showing 82% 
conversion for NtzAD+, compared to the 90% conversion when using native NAD+ (Figure 2d). Control experiments performed 
with NtzAD+ in the absence of NADK yielded little to no variation in both the absorption and emission spectra (Figure S3).[14] 
To assess the reverse reaction, NtzADPH was then subjected to treatment with S. cerevisiae glutathione reductase (GR). 
This enzyme converts oxidized glutathione (GSSG) to its reduced form (GSH) using NADPH as a cofactor, subsequently 
reducing it to NADP+.[22] As seen in Figure 2b, this enzyme was able to instantly reduce GSSG to GSH with NtzADPH. Indeed, 
an instant restoration of visible fluorescence (λex 330 nm, λem 410 nm; Figure 2b) was observed, demonstrating again the utility 
of our emissive analogues, where such enzymatic processes can be monitored by unique absorption and emission signal 
changes. 
Figure 2: a) Enzymatic cycle for NtzAD+ phosphorylation by NADK followed by G6PDH-mediated reduction of NtzADP+ to NtzADPH and final reoxidation 
of the latter by GR with GSSG as substrate. b) Time-dependent steady-state absorption and emission spectra for the enzymatic conversion of NtzAD+ to 
NtzADPH from 0 (cyan) to 180 minutes (green) and final oxidative regeneration of NtzADP+ by GR (grey and black). c) Normalized emission area over 
time for the conversion of NtzAD+ to NtzADPH (blue, λex: 330 nm) and NAD+ to NADPH (black, λex: 335 nm). d) HPLC traces monitored at 330 nm for the 
enzymatic conversion of NtzAD+ (red) to NtzADPH (blue), before the addition of NADK, after 180 min and after GR-mediated oxidation of NtzADPH to 
NtzADP+ (cyan). 
 
In this study we demonstrated that NtzAD+ could be enzymatically prepared from tzATP in a considerably higher yield when 
compared to classical synthetic pathways.[23] The nicotineamide-containing emissive cofactor can then be enzymatically 
converted to NtzADP+, which, similarly to NtzAD+, displays responsive photophysical features, allowing one to monitor 
enzymatic processes in real-time by visible emission spectroscopy. We then illustrated that those synthetic emissive 
analogues could replace the native cofactors in complex enzymatic networks. Furthermore, we finally showed that NtzADPH, 
the enzymatically generated reduced form, can be converted back to NtzADP+ using judiciously selected enzymatic reactions. 
Interestingly, this NtzADP+/NtzADPH couple showed a photophysical behavior complementary to the photophysical changes 
seen for the native NADP+ and NADPH.  
Our observations suggest that the tzA-based analogues are faithful surrogates of the corresponding native adenosine-
based cofactors. Of particular significance is the ability to perform such enzyme-mediated reactions in a sequential manner, 
exploiting in situ generated substrates and cofactors. Coupled to their useful photophysical characteristics, such synthetic 
responsive cofactors can find utility as tools for monitoring redox reactions in in vitro biophysical and discovery assays or 
potentially in living systems.  
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